Skip to search.
 STI Up 0.54%

Becton, Dickinson and Company (BDX)

-NYSE
170.66 Down 0.22(0.13%) 03:18 SGT - Nasdaq Real Time Price
Prev Close:170.88
Open:171.38
Bid:N/A
Ask:N/A
1y Target Est:186.33
Beta:0.987447
Next Earnings Date: 2-Feb-17BDX Earnings announcement
Day's Range:169.19 - 171.79
52wk Range:129.50 - 181.76
Volume:422,726
Avg Vol (3m):1,204,490
Market Cap:36.39B
P/E (ttm):38.01
EPS (ttm):4.49
Div & Yield:2.92 (1.69%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BDXDown 0.13%36.39B
BAXDown 0.27%24.96B
ABTDown 0.15%69.53B

Key Statistics

Forward P/E (1 yr):16.45
P/S (ttm):2.91
Ex-Dividend Date:07-Dec-16

Analysts

Annual EPS Est (Sep-17) :9.45
Quarterly EPS Est (Dec-16) :2.12
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):1.76

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. It operates in two segments, BD Medical and BD Life Sciences. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback